FOLD logo

Amicus Therapeutics (FOLD) CAPEX

annual CAPEX:

$3.55M-$3.89M(-52.24%)
December 31, 2024

Summary

  • As of today (May 27, 2025), FOLD annual capital expenditures is $3.55 million, with the most recent change of -$3.89 million (-52.24%) on December 31, 2024.
  • During the last 3 years, FOLD annual CAPEX has fallen by -$331.00 thousand (-8.52%).
  • FOLD annual CAPEX is now -82.25% below its all-time high of $20.01 million, reached on December 31, 2019.

Performance

FOLD CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDcash flow metrics

quarterly CAPEX:

$212.00K-$76.00K(-26.39%)
March 31, 2025

Summary

  • As of today (May 27, 2025), FOLD quarterly capital expenditures is $212.00 thousand, with the most recent change of -$76.00 thousand (-26.39%) on March 31, 2025.
  • Over the past year, FOLD quarterly CAPEX has dropped by -$1.60 million (-88.29%).
  • FOLD quarterly CAPEX is now -98.06% below its all-time high of $10.93 million, reached on December 31, 2019.

Performance

FOLD quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDcash flow metrics

TTM CAPEX:

$1.95M-$1.60M(-45.00%)
March 31, 2025

Summary

  • As of today (May 27, 2025), FOLD TTM capital expenditures is $1.95 million, with the most recent change of -$1.60 million (-45.00%) on March 31, 2025.
  • Over the past year, FOLD TTM CAPEX has dropped by -$5.36 million (-73.27%).
  • FOLD TTM CAPEX is now -90.24% below its all-time high of $20.01 million, reached on December 31, 2019.

Performance

FOLD TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDcash flow metrics

FOLD CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-52.2%-88.3%-73.3%
3 y3 years-8.5%-75.7%-49.7%
5 y5 years-82.3%-73.7%-89.1%

FOLD CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-52.2%at low-92.1%+254.7%-76.7%at low
5 y5-year-82.3%+10.1%-92.1%+254.7%-89.1%at low
alltimeall time-82.3%+1392.9%-98.1%+254.7%-90.2%+1106.2%

FOLD CAPEX History

DateAnnualQuarterlyTTM
Mar 2025
-
$212.00K(-26.4%)
$1.95M(-45.0%)
Dec 2024
$3.55M(-52.2%)
$288.00K(-19.1%)
$3.55M(-28.9%)
Sep 2024
-
$356.00K(-67.6%)
$5.00M(-19.5%)
Jun 2024
-
$1.10M(-39.4%)
$6.21M(-15.1%)
Mar 2024
-
$1.81M(+4.6%)
$7.31M(-1.8%)
Dec 2023
$7.44M(+97.6%)
$1.73M(+10.6%)
$7.44M(-11.3%)
Sep 2023
-
$1.56M(-28.9%)
$8.39M(+25.5%)
Jun 2023
-
$2.20M(+13.4%)
$6.68M(+38.2%)
Mar 2023
-
$1.94M(-27.5%)
$4.84M(+28.4%)
Dec 2022
$3.77M(-3.0%)
$2.68M(-2054.0%)
$3.77M(+32.2%)
Sep 2022
-
-$137.00K(-138.6%)
$2.85M(-26.5%)
Jun 2022
-
$355.00K(-59.2%)
$3.88M(-0.3%)
Mar 2022
-
$871.00K(-50.5%)
$3.89M(+0.1%)
Dec 2021
$3.88M(+20.4%)
$1.76M(+97.8%)
$3.88M(+21.7%)
Sep 2021
-
$890.00K(+143.2%)
$3.19M(+23.4%)
Jun 2021
-
$366.00K(-57.8%)
$2.58M(-21.4%)
Mar 2021
-
$868.00K(-18.7%)
$3.29M(+1.9%)
Dec 2020
$3.23M(-83.9%)
$1.07M(+275.7%)
$3.23M(-75.3%)
Sep 2020
-
$284.00K(-73.5%)
$13.09M(-22.0%)
Jun 2020
-
$1.07M(+32.8%)
$16.78M(-6.1%)
Mar 2020
-
$806.00K(-92.6%)
$17.87M(-10.7%)
Dec 2019
$20.01M(+217.2%)
$10.93M(+174.7%)
$20.01M(+84.9%)
Sep 2019
-
$3.98M(+83.6%)
$10.82M(+13.5%)
Jun 2019
-
$2.17M(-26.4%)
$9.54M(+13.1%)
Mar 2019
-
$2.94M(+69.5%)
$8.43M(+33.7%)
Dec 2018
$6.31M(+39.4%)
$1.74M(-35.4%)
$6.31M(+10.7%)
Sep 2018
-
$2.69M(+153.3%)
$5.70M(+38.1%)
Jun 2018
-
$1.06M(+29.7%)
$4.13M(-10.5%)
Mar 2018
-
$819.00K(-27.4%)
$4.61M(+1.9%)
Dec 2017
$4.53M(-23.9%)
$1.13M(+0.8%)
$4.53M(+18.2%)
Sep 2017
-
$1.12M(-27.7%)
$3.83M(+5.7%)
Jun 2017
-
$1.55M(+111.3%)
$3.62M(-4.8%)
Mar 2017
-
$732.00K(+69.8%)
$3.81M(-36.1%)
Dec 2016
$5.95M
$431.00K(-52.7%)
$5.95M(-26.4%)
Sep 2016
-
$912.00K(-47.3%)
$8.09M(+1.2%)
DateAnnualQuarterlyTTM
Jun 2016
-
$1.73M(-39.9%)
$8.00M(+15.2%)
Mar 2016
-
$2.88M(+11.9%)
$6.94M(+44.1%)
Dec 2015
$4.82M(+1923.9%)
$2.57M(+214.7%)
$4.82M(+110.2%)
Sep 2015
-
$817.00K(+20.9%)
$2.29M(+49.3%)
Jun 2015
-
$676.00K(-10.2%)
$1.53M(+61.4%)
Mar 2015
-
$753.00K(+1537.0%)
$951.00K(+299.6%)
Dec 2014
$238.00K(-65.8%)
$46.00K(-23.3%)
$238.00K(-1.7%)
Sep 2014
-
$60.00K(-34.8%)
$242.00K(-4.0%)
Jun 2014
-
$92.00K(+130.0%)
$252.00K(-30.6%)
Mar 2014
-
$40.00K(-20.0%)
$363.00K(-47.8%)
Dec 2013
$695.00K(-83.9%)
$50.00K(-28.6%)
$695.00K(-13.3%)
Sep 2013
-
$70.00K(-65.5%)
$802.00K(-16.5%)
Jun 2013
-
$203.00K(-45.4%)
$960.00K(-40.5%)
Mar 2013
-
$372.00K(+136.9%)
$1.61M(-62.7%)
Dec 2012
$4.32M(+204.5%)
$157.00K(-31.1%)
$4.32M(-16.7%)
Sep 2012
-
$228.00K(-73.4%)
$5.19M(+0.2%)
Jun 2012
-
$857.00K(-72.2%)
$5.18M(+16.8%)
Mar 2012
-
$3.08M(+201.6%)
$4.43M(+212.0%)
Dec 2011
$1.42M(+269.8%)
$1.02M(+373.1%)
$1.42M(+141.9%)
Sep 2011
-
$216.00K(+94.6%)
$587.00K(+36.2%)
Jun 2011
-
$111.00K(+56.3%)
$431.00K(+11.7%)
Mar 2011
-
$71.00K(-62.4%)
$386.00K(+0.5%)
Dec 2010
$384.00K(-78.7%)
$189.00K(+215.0%)
$384.00K(+38.1%)
Sep 2010
-
$60.00K(-9.1%)
$278.00K(-44.6%)
Jun 2010
-
$66.00K(-4.3%)
$502.00K(-58.5%)
Mar 2010
-
$69.00K(-16.9%)
$1.21M(-33.0%)
Dec 2009
$1.81M(-32.2%)
$83.00K(-70.8%)
$1.81M(-33.8%)
Sep 2009
-
$284.00K(-63.4%)
$2.73M(-10.5%)
Jun 2009
-
$775.00K(+16.5%)
$3.05M(-3.8%)
Mar 2009
-
$665.00K(-33.8%)
$3.17M(+18.9%)
Dec 2008
$2.67M(+298.7%)
$1.00M(+66.2%)
$2.67M(+60.4%)
Sep 2008
-
$604.00K(-32.7%)
$1.66M(+57.0%)
Jun 2008
-
$897.00K(+453.7%)
$1.06M(+553.7%)
Mar 2008
-
$162.00K
$162.00K
Dec 2007
$669.00K
-
-

FAQ

  • What is Amicus Therapeutics annual capital expenditures?
  • What is the all time high annual CAPEX for Amicus Therapeutics?
  • What is Amicus Therapeutics annual CAPEX year-on-year change?
  • What is Amicus Therapeutics quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Amicus Therapeutics?
  • What is Amicus Therapeutics quarterly CAPEX year-on-year change?
  • What is Amicus Therapeutics TTM capital expenditures?
  • What is the all time high TTM CAPEX for Amicus Therapeutics?
  • What is Amicus Therapeutics TTM CAPEX year-on-year change?

What is Amicus Therapeutics annual capital expenditures?

The current annual CAPEX of FOLD is $3.55M

What is the all time high annual CAPEX for Amicus Therapeutics?

Amicus Therapeutics all-time high annual capital expenditures is $20.01M

What is Amicus Therapeutics annual CAPEX year-on-year change?

Over the past year, FOLD annual capital expenditures has changed by -$3.89M (-52.24%)

What is Amicus Therapeutics quarterly capital expenditures?

The current quarterly CAPEX of FOLD is $212.00K

What is the all time high quarterly CAPEX for Amicus Therapeutics?

Amicus Therapeutics all-time high quarterly capital expenditures is $10.93M

What is Amicus Therapeutics quarterly CAPEX year-on-year change?

Over the past year, FOLD quarterly capital expenditures has changed by -$1.60M (-88.29%)

What is Amicus Therapeutics TTM capital expenditures?

The current TTM CAPEX of FOLD is $1.95M

What is the all time high TTM CAPEX for Amicus Therapeutics?

Amicus Therapeutics all-time high TTM capital expenditures is $20.01M

What is Amicus Therapeutics TTM CAPEX year-on-year change?

Over the past year, FOLD TTM capital expenditures has changed by -$5.36M (-73.27%)
On this page